Neurotransmitter Agents Clinical Trials

11 clinical trials for Neurotransmitter Agents across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Natural History of Depression, Bipolar Disorder and Suicide Risk — RECRUITING
• Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression — RECRUITING · PHASE2
• Nebulized Ketamine for the Treatment of Major Depressive Disorder — RECRUITING · PHASE3
• A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU) — ACTIVE_NOT_RECRUITING · PHASE3
• Efficacy of Satisens® in Reducing Emotional Eating — COMPLETED · NA
• A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States — ACTIVE_NOT_RECRUITING · PHASE3
• Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression — COMPLETED · PHASE4
• Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome — COMPLETED · PHASE4
• Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder — COMPLETED · PHASE1
• Relative Bioavailability of LY03010 Compared to Listed Drug — COMPLETED · PHASE1
• Lidocaine and Magnesium and Ketamine in Gynecological Surgery — OTHER · NA

Refine this search